 PHILADELPHIA, Aug. 17, 2021 GLOBE NEWSWIRE -- via InvestorWire -- AnPac Bio-Medical Science Co., Ltd. AnPac Bio, the Company or we NASDAQ: ANPC, a biotechnology company with operations in China and the United States, today announces that it has hired Dr. Sunil Pandit, a successful life sciences veteran and highly accomplished bio-medical scientist, as its U.S. CEO, effective Aug. 16, 2021. In his new role, Dr. Pandit will lead AnPac Bios U.S. RD and commercialization efforts to drive adoption and growth of AnPacs Cancer Differentiation Analysis CDA technology, the companys core product for cancer screening and early detection. 